Certified by Founder Lodge
Catalys Pacific
Japan - Minato-ku, Tokyo
INVESTOR
1 Disclosed Funding Rounds $150,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys Pacific has assembled a group of Strategic and Preferred Partners with whom to create as
| Company | Date | Round | Raised |
|---|---|---|---|
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Pathalys Pharma |
February, 07 ,2023 | Unknown | $150,000,000 |
Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Crystalys Therapeutics
Pathalys Pharma
Arialys Therapeutics, Inc.
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)